Abstract
BackgroundRituximab (RTX) is used in refractory paediatric rheumatic diseases (PRD). Data regarding the effects of RTX on the immune system in children and safety in PRD is scarce.ObjectivesTo prospectively evaluate...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have